From the Sector

Reset
4 results
Hologenix: CELLIANT® as a printed coating (c) Hologenix
18.12.2023

Hologenix: CELLIANT® as a printed coating

Hologenix has announced that its flagship product CELLIANT® infrared (IR) technology, a natural blend of IR-generating bioceramic minerals, is now more widely available from the company as a printed coating, expanding the uses of the technology and increasing the number of prospective partners. The innovation has already been named a Selection in the Fibers & Insulations Category of the ISPO Textrends Awards just last month.

Traditionally, CELLIANT has been embedded directly into fibers and yarns. However, for its print applications, CELLIANT fine mineral powder can be easily added directly onto the surface of all different fabric types. The company is particularly energized about how this expands the array of sustainable offerings that CELLIANT can be incorporated into, and is looking forward to partnering with brands to print CELLIANT on their ecofriendly fabrics. CELLIANT Print may be a cost-effective alternative to in-yarn solutions and allows for a more efficient supply chain.

Hologenix has announced that its flagship product CELLIANT® infrared (IR) technology, a natural blend of IR-generating bioceramic minerals, is now more widely available from the company as a printed coating, expanding the uses of the technology and increasing the number of prospective partners. The innovation has already been named a Selection in the Fibers & Insulations Category of the ISPO Textrends Awards just last month.

Traditionally, CELLIANT has been embedded directly into fibers and yarns. However, for its print applications, CELLIANT fine mineral powder can be easily added directly onto the surface of all different fabric types. The company is particularly energized about how this expands the array of sustainable offerings that CELLIANT can be incorporated into, and is looking forward to partnering with brands to print CELLIANT on their ecofriendly fabrics. CELLIANT Print may be a cost-effective alternative to in-yarn solutions and allows for a more efficient supply chain.

fabrics or to a new fabric to create a variety of different product applications. For brands who are seeking a smaller pattern roller for apparel, orthopedic products or other close-to-skin projects, CELLIANT Print can accommodate this. There is also a larger pattern roller for bedding and larger-scale applications. As long as the print covers 80% of the fabric’s surface, the design possibilities for the print itself are virtually endless. CELLIANT Print has undergone mechanical testing for wash tests and can be confirmed to last the useful life of the product, for 50+ washes.

By applying CELLIANT Print directly onto the fabric, brand partners are able to use CELLIANT with a higher loading of bioceramic minerals than what would otherwise be possible with an in-yarn solution. This makes it ideal for recovery and performance purposes. In fact, an example of a CELLIANT Print application on kinesiology tape, KT Tape® PRO Oxygen™ was launched in April to great success.

Source:

Hologenix, LLC

Celliant -how it works (c) Hologenix
06.04.2023

Hologenix: Infrared technology with potentially positive impact on diabetic patients

The diabetic community has always been a priority for Hologenix, creators of CELLIANT® infrared technology, so the company embarked on an initial study to test the hypothesis that the technology can positively impact diabetic patients with vascular impairment, now published in Journal of Textile Science & Engineering. Another study is underway as well with more research on the horizon.

The diabetic community has always been a priority for Hologenix, creators of CELLIANT® infrared technology, so the company embarked on an initial study to test the hypothesis that the technology can positively impact diabetic patients with vascular impairment, now published in Journal of Textile Science & Engineering. Another study is underway as well with more research on the horizon.

According to statistics cited in the International Diabetes Federation Diabetes Atlas, 9th edition, globally, close to a half billion people are living with diabetes and that number is expected to increase by more than 50 percent in the next 25 years.
 
The introduction of the study in the Journal of Textile Science & Engineering also reports that diabetic patients frequently suffer from a combination of peripheral neuropathy and peripheral artery disease, which particularly affects their feet. It further states that it has been estimated that the lifetime risk for the development of foot ulcers in diabetic patients can be as high as 25 percent and that the risk of amputation is 10 to 20 times higher than in non-diabetic subjects.
 
The study was performed by Lawrence A. Lavery, D.P.M., M.P.H., a Professor in the Department of Plastic Surgery at UT Southwestern Medical Center. His clinic and research interests involve diabetic foot complications, infections and wound healing, and he participated in the conception, design, implementation and authorship of the Journal of Textile Science & Engineering study.  

CELLIANT technology is a patented process for adding micron-sized thermo-responsive mineral particles to fibers, in this case polyethylene terephthalate (PET) fibers. The resulting CELLIANT yarns were woven into stockings and gloves containing either 82% CELLIANT polyester, 13% nylon and 5% spandex or for the placebo, 82% polyester with no CELLIANT, 13% nylon and 5% spandex. CELLIANT products absorb body heat and re-emit the energy back to the body as infrared energy, which is non-invasive and increases temporary blood flow and cell oxygenation levels in the body.

The objective of the study was to “evaluate changes in transcutaneous oxygen (TcPO2) and peripheral blood flow (laser Doppler, LD) in the hands and feet of diabetic patients with vascular impairment when CELLIANT gloves and stockings are worn.” While there was not a statistically significant result across all subjects, the study did show that some patients wearing CELLIANT stockings for 60 minutes had an increase of as much as 20% in tissue oxygenation and 30% in localized blood flow. According to the study’s conclusion, “the trends that were observed in favor of CELLIANT stockings suggest that a larger well-designed clinical trial should be undertaken and may provide evidence of clinical efficacy in treatment of the diabetic foot.”
 
The study also notes that “There have been no documented or observed side effects of wearing CELLIANT stockings, and they are relatively inexpensive compared to conventional pharmaceutical interventions.”

Hologenix has embarked on a more comprehensive trial, “Study to Evaluate CELLIANT Diabetic Medical Socks to Increase Tissue Oxygenation and Incidence of Complete Wound Closure in Diabetic Foot Wounds” – NCT04709419, which focuses on the impact of CELLIANT technology to potentially improve tissue oxygenation and wound healing outcomes.
 
“We are excited to explore whether future studies of infrared, with its most common biological effects of increased localized blood flow and cellular oxygenation, could result in a breakthrough in diabetic patients with vascular impairment,” said Seth Casden, Hologenix Co-founder and CEO. “We see a huge potential opportunity with this research for helping to fulfill our core mission of improving people’s health and well-being by potentially reducing the impact of diabetes, and we are actively seeking partners to expand our research efforts.”

Source:

Hologenix

13.02.2023

CELLIANT cleared to market in 50+ countries

  • Registered in majority as a class 1 medical device  

CELLIANT -  a performance textile that converts body heat into infrared energy - is designated as a Class 1 Medical Device in Australia, Canada, the EU and European Economic Area (EEA), Japan, New Zealand, the United Arab Emirates, the United Kingdom and the United States. CELLIANT is cleared to market in China, India, Indonesia, Korea, Malaysia, Mexico, Peru, Philippines, Russia, Saudi Arabia, Singapore, South Africa, Taiwan, Thailand and Vietnam, with more countries and regions to follow.

  • Registered in majority as a class 1 medical device  

CELLIANT -  a performance textile that converts body heat into infrared energy - is designated as a Class 1 Medical Device in Australia, Canada, the EU and European Economic Area (EEA), Japan, New Zealand, the United Arab Emirates, the United Kingdom and the United States. CELLIANT is cleared to market in China, India, Indonesia, Korea, Malaysia, Mexico, Peru, Philippines, Russia, Saudi Arabia, Singapore, South Africa, Taiwan, Thailand and Vietnam, with more countries and regions to follow.

In 2017, the FDA determined that products containing CELLIANT are medical devices as defined in section 201(h) of the Federal Food, Drug and Cosmetic Act and are general wellness products because they are intended to temporarily increase blood flow and local circulation at the site of the application in healthy individuals.
 
At Hologenix®, whose CELLIANT® infrared technology is an ingredient in world-class brands across many categories, science matters. The company has a distinguished Science Advisory Board composed of experts in the fields of photobiology, nanotechnology, sleep medicine, diabetes and wound care. The Science Advisory Board has overseen nine peer-reviewed published studies that collectively demonstrate CELLIANT’s effectiveness and the benefits of infrared energy. This claim set provides the basis for products containing CELLIANT to be designated as a Class 1 Medical Device in 38 countries and cleared to market in 15, with more countries and regions to follow. This elevated status in 53 countries translates to CELLIANT being an ideal partner for global companies who are seeking innovation in textiles to distinguish their products.   

“We have laid the groundwork for our partner brands to capitalize on the benefits of our infrared technology and to enhance their ability to do business,” said Seth Casden, Hologenix co-founder and CEO.  “We firmly believe that regulatory status matters and that is why we have grown the number of countries we have such relationships with by over a third in the last three years. It is definitely a competitive advantage of our company and CELLIANT.”

“Globally, the awareness of the benefits of infrared textiles, which absorb body heat and reflect it back as therapeutic infrared energy, has grown exponentially over the last 10 years,” continued Casden. “And in the United States infrared is gaining a strong foothold.”

Source:

Hologenix

(c) Hologenix
22.04.2022

DFND introduces Sleepwear powered by CELLIANT®

DFND, a compression and apparel brand designed for the military, firefighters, first responders and pro athletes, now available to athletes everywhere, has partnered with Hologenix®, creators of CELLIANT® to introduce a line of unisex sleepwear: DFND REST. Designed for the “warrior athlete,” the sleepwear is powered by DFND X CELLIANT®, the trailblazer in bio-responsive infrared textiles.
 
Both DFND and Hologenix are focused on increasing recovery and enhancing performance for the human body, so the partnership couldn’t be more ideal. CELLIANT’s science-backed infrared (IR) technology is a natural blend of bioceramics that allows textiles to capture and convert body heat into infrared energy. DFND REST powered by CELLIANT notes that it is “clinically proven to enhance tissue oxygen levels to help your body be at its best.”

DFND REST powered by CELLIANT includes three unisex designs in two colors each, Tan and Heather Grey: IR Short Sleeve V-Neck Shirt; IR Long Sleeve V-Neck Shirt and IR Sleepwear Long John; and two designs in Black: IR Recover RX Hood; IR Recover RX Jogger.

DFND, a compression and apparel brand designed for the military, firefighters, first responders and pro athletes, now available to athletes everywhere, has partnered with Hologenix®, creators of CELLIANT® to introduce a line of unisex sleepwear: DFND REST. Designed for the “warrior athlete,” the sleepwear is powered by DFND X CELLIANT®, the trailblazer in bio-responsive infrared textiles.
 
Both DFND and Hologenix are focused on increasing recovery and enhancing performance for the human body, so the partnership couldn’t be more ideal. CELLIANT’s science-backed infrared (IR) technology is a natural blend of bioceramics that allows textiles to capture and convert body heat into infrared energy. DFND REST powered by CELLIANT notes that it is “clinically proven to enhance tissue oxygen levels to help your body be at its best.”

DFND REST powered by CELLIANT includes three unisex designs in two colors each, Tan and Heather Grey: IR Short Sleeve V-Neck Shirt; IR Long Sleeve V-Neck Shirt and IR Sleepwear Long John; and two designs in Black: IR Recover RX Hood; IR Recover RX Jogger.

DFND REST, like all DFND products, is designed, tested and made in the USA. CELLIANT’s proprietary mineral formula is processed and manufactured in the USA.

DFND REST will be featured at the following upcoming shows: the Holistic Health and Fitness (H2F) Exposition and Industry Day, April 26 to 27 at Fort Eustis; Warrior West, April 27 to 28 at the San Diego Convention Center; Modern Day Marine, May 10 to 12, Washington, D.C.; The Human Performance & Biosystems Summit, June 29 to 30 at National Harbor, Maryland; National Guard Conference & Exhibition, August 26 to 29, Columbus, Ohio; and AUSA, October 10 to 12, Washington, D.C.

More information:
Celliant DFND sleepwear
Source:

Hologenix / Sarah P. Fletcher Communications